GlassScriptPhysician profile
Alec Fletcher
NPI 1285262337
$2,347.54
in general payments reported to CMS, 2019-2025
14 companies · $1,415 in 2025
The $1,415 reported for 2025 was more than what 89% of Internal Medicine providers received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2024: $933 · 2025: $1,415.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,016 · Education: $331.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,016.21 |
| Education | $331.33 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $649.84 | 2024-2025 | Cardiomems, Ensite |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $624.02 | 2024-2025 | Lifevest |
| Astrazeneca Pharmaceuticals LP | $316.03 | 2024-2025 | Farxiga, Wainua |
| Boston Scientific Corporation | $162.51 | 2024-2025 | Emblem Mri S-Icd, Zoom Wireless Transmitter |
| Zoll Circulation INC | $135.00 | 2024 | Downstream Cartridge, Therox Ds2 Console, Catheter |
| Novartis Pharmaceuticals Corporation | $110.02 | 2024-2025 | |
| Idorsia Pharmaceuticals US INC | $89.72 | 2024 | Tryvio |
| Irhythm Technologies, INC. | $89.58 | 2024 | Zio Monitor, Zio Xt Patch |
| Novo Nordisk INC | $54.01 | 2025 | Wegovy |
| Boehringer Ingelheim Pharmaceuticals, INC. | $39.10 | 2024-2025 | Jardiance |
| Abiomed | $24.65 | 2024 | Impella |
| Cvrx, INC. | $22.12 | 2025 | Barostim Neo System |
| Janssen Pharmaceuticals, INC | $16.05 | 2024 | Xarelto |
| Chiesi USA, INC. | $14.89 | 2025 | Kengreal |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Alec Fletcher listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.